Radiological differences between chronic thromboembolic pulmonary disease (CTEPD) and chronic thromboembolic

Carmine Capone1,2, Adele Valentini3, Silvia Lina Spinillo1

  • 1Department of Clinical, Surgical, Pediatric and Diagnostic Sciences, Faculty of Medicine and Surgery, University of Pavia, Pavia, Italy.

European Radiology
|January 28, 2021
PubMed

Insights

Radiological features of chronic thromboembolic pulmonary disease (CTEPD) differ from chronic thromboembolic pulmonary hypertension (CTEPH). Absence of microvascular disease in CTEPD may explain the lack of pulmonary hypertension.

Area of Science:

  • Radiology
  • Pulmonary Medicine
  • Cardiovascular Imaging

Background:

  • Chronic thromboembolic pulmonary disease (CTEPD) radiological features require systematic description.
  • Understanding CTEPD's distinct pathophysiology from CTEPH is crucial for diagnosis and management.

Purpose of the Study:

  • To delineate the radiological characteristics of CTEPD.
  • To compare vascular scores between CTEPD and CTEPH patients.
  • To investigate the reasons for the absence of resting pulmonary hypertension in CTEPD.

Main Methods:

  • Dual-energy computed tomography pulmonary angiography (DE-CTPA) with iodine perfusion maps was used in 85 patients (40 CTEPD, 45 CTEPH).
  • CT scans were independently reviewed for vascular obstruction, hypoperfusion, mosaic attenuation, and signs of pulmonary hypertension.
  • Single-source CTPA was performed in an additional 6 CTEPD patients.

Main Results:

  • Vascular obstruction burden was similar between CTEPD and CTEPH groups.
  • CTEPD patients showed significantly smaller perfusion defects on iodine maps and less mosaic attenuation, suggesting absent microvascular disease.
  • Indirect signs of pulmonary hypertension were significantly different between the two groups.

Conclusions:

  • CTEPD and CTEPH exhibit distinct radiological features, including signs of pulmonary hypertension, mosaic attenuation, and perfusion patterns.
  • The absence of peripheral microvascular disease in CTEPD, despite significant thrombotic burden, likely prevents the development of pulmonary hypertension.
  • These findings aid in differentiating CTEPD from CTEPH based on imaging.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
415
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
262
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
114
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
124
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.8K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
314